Bridgeway Capital Management’s Evelo Biosciences, Inc. Common Stock EVLO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-5,265
| Closed | -$19K | – | 1478 |
|
|
2023
Q1 | $19K | Hold |
5,265
| – | – | ﹤0.01% | 1357 |
|
|
2022
Q4 | $170K | Hold |
5,265
| – | – | ﹤0.01% | 1124 |
|
|
2022
Q3 | $220K | Buy |
+5,265
| New | +$220K | 0.01% | 1124 |
|
|
2020
Q3 | – | Sell |
-3,425
| Closed | -$336K | – | 1373 |
|
|
2020
Q2 | $336K | Sell |
3,425
-3,250
| -49% | -$319K | 0.01% | 1007 |
|
|
2020
Q1 | $501K | Hold |
6,675
| – | – | 0.01% | 760 |
|
|
2019
Q4 | $542K | Buy |
+6,675
| New | +$542K | 0.01% | 950 |
|